Dangerous hay fever jab which was banned due to its 'serious side effects' is being promoted by private clinic despite crackdown on illegal ads
The Medicines & Healthcare products Regulatory Agency (MHRA) has taken action against one practice which was found to be advertising triamcinolone, also known as Kenalog. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2024 Category: Consumer Health News Source Type: news
Aristospan Injection 20 mg (Triamcinolone Hexacetonide Injectable Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 30, 2022 Category: Drugs & Pharmacology Source Type: news
Intra-Articular Injection of Triamcinolone Beneficial in Hip Osteoarthritis
FRIDAY, April 8, 2022 -- For patients with hip osteoarthritis and at least moderate pain, an ultrasound-guided intra-articular hip injection of corticosteroid and local anesthetic, administered with advice and education, is effective versus advice... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2022 Category: Pharmaceuticals Source Type: news
Alembic Pharmaceuticals' JV gets USFDA final nod for anti-fungal drug
The approval by the US Food& Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment of strength 100,000 units/gram, Alembic Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 8, 2022 Category: Pharmaceuticals Source Type: news
FDA Approves Drugs for Wet AMD, Macular Edema Due to Uveitis FDA Approves Drugs for Wet AMD, Macular Edema Due to Uveitis
Wet AMD gets Susvimo, an intravitreal ranibizumab injection, and macular edema gets Xipere, a triamcinolone acetonide injectable suspension.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 26, 2021 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news
FDA Approves Xipere (triamcinolone acetonide injectable suspension) for the Treatment of Macular Edema Associated with Uveitis
XIPERE™ is the First and Only Medicine to be Approved in the United States for Delivery via Suprachoroidal Injection, a Method Designed to Facilitate Targeted Delivery of Therapeutic Agents to the Retina and Choroid
LAVAL, QC and ALPHARETTA,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 25, 2021 Category: Drugs & Pharmacology Source Type: news
Triesence (triamcinolone acetonide)
Title: Triesence (triamcinolone acetonide)Category: MedicationsCreated: 7/8/2021 12:00:00 AMLast Editorial Review: 7/8/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 8, 2021 Category: Rheumatology Source Type: news
What Are Some Indications for Using Dexamethasone?
Discussion
Corticosteroids are a group of drugs which can be naturally or synthetically produced. Naturally occurring substances are produced in the adrenal gland, and are protein-bound (primarily corticosteroid-binding globulin and albumin). In the target tissues, they may need to be converted to an active substance. They are then reduced, oxidized, hydroxylated or conjugated as measures to inactivate them. Synthetic steroids have less protein binding and depending on their structure are more or less resistant to inactivation. Prednisone is the glucocorticoid most often used for treatment, especially as it has a short hal...
Source: PediatricEducation.org - June 7, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Trianex (triamcinolone acetonide)
Title: Trianex (triamcinolone acetonide)Category: MedicationsCreated: 5/25/2021 12:00:00 AMLast Editorial Review: 5/25/2021 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - May 25, 2021 Category: Dermatology Source Type: news
Nasacort AQ (Triamcinolone Acetonide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 21, 2021 Category: Drugs & Pharmacology Source Type: news
Ellzia Pak (Triamcinolone Acetonide Ointment ) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 26, 2020 Category: Drugs & Pharmacology Source Type: news
Ellzia Pak (triamcinolone acetonide ointment, dimethicone)
Title: Ellzia Pak (triamcinolone acetonide ointment, dimethicone)Category: MedicationsCreated: 10/22/2020 12:00:00 AMLast Editorial Review: 10/22/2020 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - October 22, 2020 Category: Dermatology Source Type: news
Strides Pharma gets USFDA nod for generic ointment to treat skin conditions
Strides Pharma Science on Tuesday said it has received US health regulator's approval for its generic version of triamcinolone acetonide ointment used for treatment of various skin conditions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 1, 2020 Category: Pharmaceuticals Source Type: news
Zilretta (Triamcinolone Acetonide Extended-Release Injectable Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 3, 2020 Category: Drugs & Pharmacology Source Type: news
Bausch Health Licenses Clearside Biomedical's XIPERE(TM) (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
NDA Resubmission to the FDA Expected to Occur in the First Quarter of 2020
LAVAL, Quebec and ALPHARETTA, Ga., Oct. 23, 2019 -- (Healthcare Sales & Marketing Network) -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch... Biopharmaceuticals, Ophthalmology, Licensing Bausch Health Companies, Bausch & Lomb, Clearside Biomedical, XIPERE, Uveitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 23, 2019 Category: Pharmaceuticals Source Type: news
